Navigated and individual α-peak-frequency–guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia
Journal of Psychiatry and Neuroscience · 2024
DOI: 10.1503/jpn.230063 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Psychiatry and Neuroscience, 2024. Verfasst von Heli Tuppurainen und 11 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland (Tuppurainen, Hyvärinen, Vaurio, Joe…. Hauptthemen laut MEDLINE: Schizophrenia, Transcranial Magnetic Stimulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Previous electroencephalography (EEG) studies have indicated altered brain oscillatory α-band activity in schizophrenia, and treatment with repetitive transcranial magnetic stimulation (rTMS) using individualized α-frequency has shown therapeutic effects. Magnetic resonance imaging–based neuronavigation methods allow stimulation of a specific cortical region and improve targeting of rTMS; therefore, we sought to study the efficacy of navigated, individual α-peak-frequency–guided rTMS (αTMS) on treatment-refractory schizophrenia.
Methods
We recruited medication-refractory male patients with schizophrenia or schizoaffective disorder in this doubleblind, sham-controlled study. We randomized patients to a 3-week course of either active αTMS or sham stimulation applied to the left dorsolateral prefrontal cortex (DLPFC). We assessed participants with the Positive and Negative Syndrome Scale (PANSS) and the Clinical Global Impression Scale (CGI) at baseline and after treatment. We conducted a follow-up assessment with the PANSS 3 months after intervention.
Results
We included 44 patients. After treatment, we observed a significantly higher PANSS total score ( p = 0.029), PANSS general psychopathology score ( p = 0.027) and PANSS 5-factor model cognitive–disorganized factor score ( p = 0.011) in the αTMS group than the sham group. In addition, the CGI–Improvement score was significantly higher among those who received αTMS compared with sham stimulation ( p = 0.048).
Limitations
The limited number of study participants included only male patients. Depression was not formally evaluated.
Conclusion
Navigated αTMS to the left DLPFC reduced total, general psychopathological, and cognitive–disorganized symptoms of schizophrenia. These results provide evidence for the therapeutic efficacy of individual α-peak-frequency–guided rTMS in treatment-refractory schizophrenia. Clinical trial registration: NCT01941251; ClinicalTrials.gov
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland (Tuppurainen, Hyvärinen, Vaurio, Joensuu, Vanhanen, Aho-Mustonen, Tiihonen); the Department of Clinical Ne…
Zitieren
APA
Tuppurainen, H., Määttä, S., Könönen, M., Julkunen, P., Kautiainen, H., Hyvärinen, S., Vaurio, O., Joensuu, M., Vanhanen, M., Aho-Mustonen, K., Mervaala, E., & Tiihonen, J. (2024). Navigated and individual α-peak-frequency–guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia. Journal of Psychiatry and Neuroscience. https://doi.org/10.1503/jpn.230063
Vancouver
Tuppurainen H, Määttä S, Könönen M, Julkunen P, Kautiainen H, Hyvärinen S, et al. Navigated and individual α-peak-frequency–guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia. Journal of Psychiatry and Neuroscience. 2024. doi:10.1503/jpn.230063
BibTeX
@article{Tuppurainen2024,
author = {Tuppurainen, Heli and Määttä, Sara and Könönen, Mervi and Julkunen, Petro and Kautiainen, Hannu and Hyvärinen, Soile and Vaurio, Olli and Joensuu, Mikko and Vanhanen, Matti and Aho-Mustonen, Kati and Mervaala, Esa and Tiihonen, Jari},
title = {Navigated and individual α-peak-frequency–guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia},
journal = {Journal of Psychiatry and Neuroscience},
year = {2024},
doi = {10.1503/jpn.230063}
}
EUVIMED